ページ内を移動するためのリンクです。

IR Materials

IR Presentations

Tolvaptan REPRISE phase 3 trial results in polycystic kidney disease
November 4, 2017

Information Meeting for the Acquisition of Avanir Pharmaceuticals
December 2, 2014

Second Medium-Term Management Plan August 26, 2014

First Medium-Term Management Plan May 16, 2011